Mantilla, Charlemagne L.

HRN: 28-65-80  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/10/2026
CEFTRIAXONE 1G (VIAL)
03/10/2026
03/17/2026
IV
2g
Q24
Galeazzi Fracture Dislocation
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Skin & Soft TissueProphylaxis    Compliance to guidelines: